18/04/2019 (Agence Europe) – On Wednesday, 17 April, the European Parliament adopted a targeted revision of patent rules applicable to pharmaceutical products (see EUROPE B12194A4). The new regulation allows European pharmaceutical companies to export generic and biosimilar medicines to non-EU countries where intellectual property protection has expired or never existed. At the request of the European Parliament, it also enables these companies to build up a stock of generics during...